Australian drug regulator takes action over claims products can treat disease

Therapeutic Goods Administration takes on Peptides Clinics Australia for alleged advertising breaches

For the first time in almost a decade Australia's drugs regulator has begun court action against a supplements seller, after the online company claimed its products could help people build muscle while also treating anxiety, depression, heart damage, joint diseases, bone diseases and other ailments.

The Therapeutics Goods Administration (TGA) alleges Peptide Clinics Australia advertised prescription-only therapeutic goods including peptides on its website and other social media platforms. The online seller did not have TGA approval to state its products could treat diseases.